Showing results (91-100 of 193) with videos related to

Sort By:
Pageof 20
AIDS (London, England)|May 1, 1987
Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complexC F Farthing, A G Dalgleish, A Clark, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseK J O'Byrne, A G Dalgleish, M J Browning, et al.
The Lancet. Oncology|March 21, 2002
Angiogenesis as a biomarker and target in cancer chemopreventionR A Sharma, A L Harris, A G Dalgleish, et al.
The British Journal of Dermatology|July 12, 2008
Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanomaD S Green, A G Dalgleish, N Belonwu, et al.
AIDS (London, England)|February 1, 1990
Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive peopleD Wilks, L C Walker, J A Habeshaw, et al.
British Journal of Urology|January 12, 1999
Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancerD Hrouda, B E Souberbielle, J Kayaga, et al.
Lancet (London, England)|April 4, 1992
T-cell receptor variable gene products and early HIV-1 infectionA G Dalgleish, S Wilson, M Gompels, et al.
British Journal of Cancer|October 6, 2011
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cellsN Ioannou, A G Dalgleish, A M Seddon, et al.
British Journal of Cancer|July 30, 2009
Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)W M Liu, J Y Henry, B Meyer, et al.
European Journal of Immunology|January 1, 1993
Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clonesF Manca, J A Habeshaw, A G Dalgleish, et al.
Pageof 20